Commonwealth legislation

National Health Act 1953 - Declaration under subsection 85(2AA) (30/03/1988)

RepealedCTH

This Act has been repealed and is no longer in force. It is retained for historical reference.

Jurisdiction

Commonwealth

Collection

legislative instrument

Plain English Summary

2/10 complexity

This declaration removes 17 specific medicines from Australia’s Pharmaceutical Benefits Scheme, so from 1 April 1988 patients who had them subsidised must pay full commercial prices or seek alternatives. It matters because delisting ends their status as “pharmaceutical benefits” — typically done when cheaper substitutes exist, drugs are obsolete, or funding/policy decisions stop government subsidy.

JSON API Health / NDIS / medicines

Deep dive

Want the full deep dive?

Zoe can write the in-depth analysis on top of the summary above: how it works, who it affects and what each part actually does.

Current sections

Direct links to the current provisions in National Health Act 1953 - Declaration under subsection 85(2AA) (30/03/1988).

National Health Act 1953 - Declaration under subsection 85(2AA) (30/03/1988)

View image in the official sourceCOMMONWEALTH OF AUSTRALIA
NATIONAL HEALTH ACT 1953
PHARMACEUTICAL BENEFITS
DECLARATION UNDER SUB-SECTION 85(2AA)

I, JOHN STEWART DEEBLE, Acting First Assistant Secretary, Health Benefits Division, Department of Community Services and Health and Delegate of the Minister of State for Community Services and Health, pursuant to sub-section 85(2AA) of the National Health Act 1953, hereby make the following Declaration:

This Declaration shall come into operation on 1 April 1988.
The drugs and medicinal preparations contained in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.

THE SCHEDULE

Chloroquine Sulphate Injection B.P.

Chlortetracycline

Chlortetracycline Hydrochloride B.P.

Clorexolone

Ergocalciferol B.P.

Ethanolamine Oleate Injection B.P.

Fluphenazine Hydrochloride B.P.

"Galactomin, Formula No. 17"

Iron Sorbitol Injection B.P.

Liothyronine Tablets B.P.

Magenta B.P.C. 1973

Norgestrel with Ethinyloestradiol B.P.

Oxytetracycline Hydrochloride B.P.

Prednisolone B.P.

Sodium Lactate Intravenous Infusion B.P.

Sulphafurazole Tablets B.P.

Sulphapyridine Tablets B.P.

"Zerodor"

View image in the official sourceDated this 30th day of March 1988.

JOHN DEEBLE

ACTING FIRST ASSISTANT SECRETARY

HEALTH BENEFITS DIVISION

DELEGATE OF THE MINISTER OF STATE FOR COMMUNITY SERVICES AND HEALTH

Source text

Sourced from the Federal Register of Legislation (legislation.gov.au), CC BY 4.0.

1 National Health Act 1953 - Declaration under subsection 85(2AA) (30/03/1988)

COMMONWEALTH OF AUSTRALIA
NATIONAL HEALTH ACT 1953
PHARMACEUTICAL BENEFITS
DECLARATION UNDER SUB-SECTION 85(2AA)

This Declaration shall come into operation on 1 April 1988.
The drugs and medicinal preparations contained in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.